These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1394571)

  • 1. [Multiple (serial) poisoning with scopolamine present in a compounded nose drop preparation].
    Marx D; Janecková M; Kmínek A
    Cesk Pediatr; 1992 Sep; 47(9):553-5. PubMed ID: 1394571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case report: Hyperthermia and diminished consciousness in an elderly woman following an accidental overdose of scopolamine.
    Van de Velde K; Siau B; Vermeulen G
    Acta Neurol Belg; 2015 Sep; 115(3):517-8. PubMed ID: 25395072
    [No Abstract]   [Full Text] [Related]  

  • 3. [Drug facilitated crime using burundanga: First analytical confirmation in Spain].
    Gomila Muñiz I; Puiguriguer Ferrando J; Quesada Redondo L
    Med Clin (Barc); 2016 Nov; 147(9):421. PubMed ID: 27567338
    [No Abstract]   [Full Text] [Related]  

  • 4. [Scopolamine poisoning as a cause of acute paranoid hallucinatory psychoses].
    Ziegler B; Tönjes W
    Psychiatr Prax; 1991 Jan; 18(1):21-4. PubMed ID: 2027913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Death caused by therapeutic doses of morphine or morphinescopolamine in subjects under influence of alcohol or barbiturates].
    Møller KO
    Tidsskr Nor Laegeforen; 1953 Jan; 73(1):1-8. PubMed ID: 13049273
    [No Abstract]   [Full Text] [Related]  

  • 6. Microdialysis pharmacokinetic study of scopolamine in plasma, olfactory bulb and vestibule after intranasal administration.
    Wei Y; Ying M; Xu S; Wang F; Zou A; Cao S; Jiang X; Wang Y
    Drug Deliv; 2016; 23(1):263-8. PubMed ID: 24865285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose escalation pharmacokinetics of intranasal scopolamine gel formulation.
    Wu L; Boyd JL; Daniels V; Wang Z; Chow DS; Putcha L
    J Clin Pharmacol; 2015 Feb; 55(2):195-203. PubMed ID: 25187210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delirium induced by poisoning with anticholinergic agents.
    Brizer DA; Manning DW
    Am J Psychiatry; 1982 Oct; 139(10):1343-4. PubMed ID: 7124991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic errors. The atropine syndrome (Appien-Plutarque syndrome)].
    Nemery A; Duvivier A; Delcour C; Mouchette R
    Rev Med Liege; 1983 Dec; 38(24):927-9. PubMed ID: 6366958
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prevention of kinetosis in children. Transdermal therapy with scopolamine].
    Müller M; Besch W; Steilner D
    Fortschr Med; 1987 Feb; 105(4):82, 86-7. PubMed ID: 3557264
    [No Abstract]   [Full Text] [Related]  

  • 11. Million dollar ride: Crime committed during involuntary scopolamine intoxication.
    Reichert S; Lin C; Ong W; Him CC; Hameed S
    Can Fam Physician; 2017 May; 63(5):369-370. PubMed ID: 28500194
    [No Abstract]   [Full Text] [Related]  

  • 12. Intranasal scopolamine affects the semicircular canals centrally and peripherally.
    Weerts AP; Putcha L; Hoag SW; Hallgren E; Van Ombergen A; Van de Heyning PH; Wuyts FL
    J Appl Physiol (1985); 2015 Aug; 119(3):213-8. PubMed ID: 25953832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation of ion-activated in situ gel systems of scopolamine hydrobromide and evaluation of its antimotion sickness efficacy.
    Cao SL; Zhang QZ; Jiang XG
    Acta Pharmacol Sin; 2007 Apr; 28(4):584-90. PubMed ID: 17376300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restricted sedation and absence of cognitive impairments after administration of intranasal scopolamine.
    Weerts AP; Pattyn N; Putcha L; Hoag SW; Van Ombergen A; Hallgren E; Van de Heyning PH; Wuyts FL
    J Psychopharmacol; 2015 Dec; 29(12):1231-5. PubMed ID: 26268532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Death caused by therapeutic doses of morphine or morphinescopolamine in persons under influence of alcohol or barbiturate].
    Møller KO
    Ugeskr Laeger; 1952 Dec; 114(50):1785-93. PubMed ID: 13049629
    [No Abstract]   [Full Text] [Related]  

  • 16. Widespread hyoscine hydrobromide toxicity due to contract manufacturer malpractice : the travacalm episode.
    McEwen J; Thompson BR; Purcell PM; Kelly LF; Krauss AS
    Drug Saf; 2007; 30(5):375-8. PubMed ID: 17472417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioavailability of intranasal scopolamine in normal subjects.
    Putcha L; Tietze KJ; Bourne DW; Parise CM; Hunter RP; Cintrón NM
    J Pharm Sci; 1996 Aug; 85(8):899-902. PubMed ID: 8863287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous scopolamine is potently self-administered in drug-naive mice.
    Rasmussen T; Fink-Jensen A
    Neuropsychopharmacology; 2000 Jan; 22(1):97-9. PubMed ID: 10633495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From the Centers for Disease Control and Prevention. Scopolamine poisoning among heroin users--New York City, Newark, Philadelphia, and Baltimore, 1995 and 1996.
    JAMA; 1996 Jul; 276(2):92-3. PubMed ID: 8656517
    [No Abstract]   [Full Text] [Related]  

  • 20. Donnatal intoxication: case report.
    Herskowitz A; Blustein W; Graebner R
    Mil Med; 1974 May; 139(5):397. PubMed ID: 4209003
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.